Scientific reports

Journal of theoretical biology

human vaccines & immunotherapeutics

Inflammopharmacology

immunotherapy

[1] Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.

[2] Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients.

[3] A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge.

[4] Impact of influenza vaccine-modified infectivity on attack rate, case fatality ratio and mortality.

[5] influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion

[6] experimental approaches to study genome packaging of influenza a viruses

[7] modified vaccinia virus ankara (mva) as production platform for vaccines against influenza and other viral respiratory diseases

[8] new kids on the block: rna-based influenza virus vaccines

[9] comparison of mortality associated with respiratory viral infections between december 2019 and march 2020 with that of the previous year in southeastern france

[10] genetic variation and drug resistance mutation of influenza virus during 2013-2014 in beijing, china: a report of 37 cases

[11] large-scale analysis of b-cell epitopes on influenza virus hemagglutinin - implications for cross-reactivity of neutralizing antibodies

[12] ns segment of a 1918 influenza a virus-descendent enhances replication of h1n1pdm09 and virus-induced cellular immune response in mammalian and avian systems

[13] assessment of the rnasound rna sampling card for the preservation of influenza virus rna

[14] un-“escrt”-ed budding

[15] san wu huangqin decoction, a chinese herbal formula, inhibits influenza a/pr/8/34 (h1n1) virus infection in vitro and in vivo

[16] carbonate apatite nanoparticles act as potent vaccine adjuvant delivery vehicles by enhancing cytokine production induced by encapsulated cytosine-phosphate-guanine oligodeoxynucleotides

[17] antiviral decoction of isatidis radix (板藍根 bǎn lán gēn) inhibited influenza virus adsorption on mdck cells by cytoprotective activity

[18] therapeutic impact of human serum albumin-thioredoxin fusion protein on influenza virus-induced lung injury mice

[19] influenza virus and endothelial cells: a species specific relationship

[20] Triple combination therapy of favipiravir plus two monoclonal antibodies eradicates influenza virus from nude mice

[21] The added value of online user-generated content in traditional methods for influenza surveillance - Scientific Reports

[22] The added value of online user-generated content in traditional methods for influenza surveillance - Scientific Reports

[23] Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017

[24] Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017

[25] Human parainfluenza virus-associated respiratory tract infection among children and genetic analysis of HPIV-3 strains in Beijing, China.

[26] Editorial: Epidemiology of Avian Influenza Viruses.

[27] Polygalasaponin F treats mice with pneumonia induced by influenza virus.

[28] A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice

[29] Activity of isatine-sulfadimidine derivatives against 2009 pandemic H1N1 influenza virus in cell culture.

[30] Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens.

[31] Intercontinental spread of Asian-origin H7 avian influenza viruses by captive bird trade in 1990's.

[32] The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo.

[33] New molecular evolutionary characteristics of H9N2 avian influenza virus in Guangdong Province, China.

[34] Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season.

[35] Risk factors for H5 avian influenza virus prevalence on urban live bird markets in Jakarta, Indonesia-Evaluation of long-term environmental surveillance data.

[36] Experimental Approaches to Identify Host Factors Important for Influenza Virus.

[37] Zoonosis Update on H9N2 Avian Influenza Virus

[38] A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge.

[39] Hormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy

[40] Structure and Hierarchy of Influenza Virus Models Revealed by Reaction Network Analysis.

[41] RNA Extraction from Equine Samples for Equine Influenza Virus.

[42] Predicting the short-term success of human influenza virus variants with machine learning.

[43] The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro

[44] ECOLOGICAL DETERMINANTS OF AVIAN INFLUENZA VIRUS, WEST NILE VIRUS, AND AVIAN PARAMYXOVIRUS INFECTION AND ANTIBODY STATUS IN BLUE-WINGED TEAL (ANAS DISCORS) IN THE CANADIAN PRAIRIES.

[45] Cloning, expression, and purification of the recombinant hemagglutinin of human influenza virus H1N1 in the eukaryotic insect cells using baculovirus vector

[46] Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection

[47] Protective Efficacy of Seasonal Influenza Vaccination against Seasonal and Pandemic Influenza Virus Infection during 2009 in Hong Kong

[48] Pathogenesis of Severe Acute Respiratory Infections in the Developing World: Respiratory Syncytial Virus and Parainfluenza Viruses

[49] Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

[50] Pathogenesis of Respiratory Infections Due to Influenza Virus: Implications for Developing Countries

[51] Incidence of Influenza Virus Infections in Children in Hong Kong in a 3-Year Randomized Placebo-Controlled Vaccine Study, 2009–2012

[52] Pathogenesis of Respiratory Infections Due to Influenza Virus: Implications for Developing Countries

[53] Effects of Oseltamivir Treatment on Duration of Clinical Illness and Viral Shedding and Household Transmission of Influenza Virus

[54] Clinical and epidemiological characterization of influenza virus infections in children with severe acute respiratory infection in Maputo, Mozambique: Results from the implementation of sentinel surveillance, 2014 – 2016

[55] Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections

[56] Clinical and epidemiological characterization of influenza virus infections in children with severe acute respiratory infection in Maputo, Mozambique: Results from the implementation of sentinel surveillance, 2014 - 2016

[57] An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines

[58] Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

[59] expression of concern on “modes of antiviral action of chemical portions and constituents from woad root extract against influenza virus a fm1”

[60] influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion

[61] dryocrassin abba, a novel active substance for use against amantadine-resistance h5n1 avian influenza virus

[62] epidemiology and clinical presentation of the four human parainfluenza virus types

[63] paivs: prediction of avian influenza virus subtype

[64] disulfide isomerase erp57 improves the stability and immunogenicity of h3n2 influenza virus hemagglutinin

[65] the impact of climate and antigenic evolution on seasonal influenza virus epidemics in australia

[66] intranasal vaccination with an engineered influenza virus expressing the receptor binding subdomain of botulinum neurotoxin provides protective immunity against botulism and influenza

[67] contribution of the purinergic receptor p2x7 to development of lung immunopathology during influenza virus infection

[68] intranasal immunization with influenza virus-like particles containing membrane-anchored cholera toxin b or ricin toxin b enhances adaptive immune responses and protection against an antigenically distinct virus

[69] presença do vírus da gripe no sangue e órgãos de animais inoculados por via intracardíaca presence of the influenza virus in the blood and organs of animals inoculated by intracardiac route

[70] new kids on the block: rna-based influenza virus vaccines

[71] dendritic cells in innate and adaptive immune responses against influenza virus

[72] virus shedding in co-infections of low pathogenic avian influenza virus ( h6n2 ) and lentogenic newcastle disease virus (la sota) in numida meleagris

[73] a hypothesis: supplementation with mushroom-derived active compound modulates immunity and increases survival in response to influenza virus (h1n1) infection

[74] examination of pathological process pecularities caused by a/duck/altai/469/14 h5n1 isolate of avian influenza virus in chickens

[75] chemical genomics identifies the perk-mediated unfolded protein stress response as a cellular target for influenza virus inhibition

[76] influenza virus segment composition influences viral stability in the environment

[77] estudo sorológico sobre a cepa a/new jersey/8/76 em grupos populacionais brasileiros: nota prévia serologic study of the a/new jersey/8/76 influenza virus in brazilian population groups: communication

[78] comparison of porcine airway and intestinal epithelial cell lines for the susceptibility and expression of pattern recognition receptors upon influenza virus infection

[79] geldanamycin reduces acute respiratory distress syndrome and promotes the survival of mice infected with the highly virulent h5n1 influenza virus

[80] erratum for gui et al., electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: association of receptor binding and fusion proteins before receptor engagement

[81] initial influenza virus replication can be limited in allergic asthma through rapid induction of type iii interferons in respiratory epithelium

[82] dual acting neuraminidase inhibitors open new opportunities to disrupt the lethal synergism between streptococcus pneumoniae and influenza virus

[83] mx bio adjuvant for enhancing immune responses against influenza virus

[84] a review: evaluating the dynamics of influenza viruses replication and host cell- virus interactions

[85] current approaches for diagnosis of influenza virus infections in humans

[86] genetic variation and drug resistance mutation of influenza virus during 2013-2014 in beijing, china: a report of 37 cases

[87] cytokine profiles of severe influenza virus-related complications in children

[88] large-scale analysis of b-cell epitopes on influenza virus hemagglutinin - implications for cross-reactivity of neutralizing antibodies

[89] characterisation and identification of avian influenza virus (ai)

[90] assessment of the rnasound rna sampling card for the preservation of influenza virus rna

[91] rare sox2+ airway progenitor cells generate krt5+ cells that repopulate damaged alveolar parenchyma following influenza virus infection

[92] generation of adaptive immune responses following influenza virus challenge is not compromised by pre-treatment with the tlr-2 agonist pam2cys

[93] characterization and epidemiology of influenza viruses in patients seeking treatment for influenza-like illnesses in rural bangladesh

[94] genetical evaluation of resistance to amantadine in h9n2 avian influenza virus in iran between 1998 to 2009

[95] mucosa-associated lymphoid tissue lymphoma translocation protein 1 positively modulates matrix metalloproteinase-9 production in alveolar macrophages upon toll-like receptor 7 signaling and influenza virus infection

[96] characterisation of enzymatic activities of h5n1 influenza virus

[97] antiviral decoction of isatidis radix (板藍根 bǎn lán gēn) inhibited influenza virus adsorption on mdck cells by cytoprotective activity

[98] therapeutic impact of human serum albumin-thioredoxin fusion protein on influenza virus-induced lung injury mice

[99] the application of nhej-crispr/cas9 and cre-lox system in the generation of bivalent duck enteritis virus vaccine against avian influenza virus

[100] influenza virus and endothelial cells: a species specific relationship

[101] the effect of virgin coconut oil on lymphocyte and cd4 in chicken vaccinated against avian influenza virus